DENTSPLY SIRONA(XRAY) - 2024 Q2 - Quarterly Results

Q2 24 Summary Results (GAAP) • Net sales of $984 million decreased (4.2%), organic sales decreased (2.3%) • GAAP gross margin of 51.9%, GAAP net loss of ($ 4) million or loss per share of ( $0.02) • Adjusted EBITDA margin of 17.5%, adjusted EPS of$ 0.49 • Revised FY24 outlook: organic sales down (1%) to flat (previously flat to up 1.5%); adjusted EPS of $1.96 to$ 2.02 (previously $2.00 to$ 2.10) • Company repurchased $150 million of its common stock in Q2 2024; expects to repurchase$ 100 million of its common ...